Dermatology News

Dermatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Blome C et al. – The PBI–HE is a feasible, reliable, and valid instrument for the assessment of patient–relevant treatment benefits in CHE.

Related Articles

Filaggrin mutations in the onset of eczema, sensitization, asthma, hay fever and the interaction with cat exposure
Allergy, 11/17/09    Relevance Score: 89%

Eczema: what lies beneath
Nurse Prescribing, 10/08/09    Relevance Score: 89%

Eczema, respiratory allergies, and traffic-related air pollution in birth cohorts from small-town areas
Journal of Dermatological Science, 10/06/09    Relevance Score: 89%

Pruritis part 1: Atopic eczema
Practice Nursing, 11/11/09    Relevance Score: 88%

Perinatal exposure to endotoxin and the development of eczema during the first 6 years of life
Clinical and Experimental Dermatology, 11/16/09    Relevance Score: 87%

Today in Derm Allergy/Immunology...keeping you current

Acquired perforating dermatosis associated with pregnancy
Clinical and Experimental Dermatology, 12/16/09

A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria
Annals of Allergy, Asthma, and Immunology, 12/16/09

Bacterial Burden of Worn Therapeutic Silver Textiles for Neurodermitis Patients and Evaluation of Efficacy of Washing
Skin Pharmacology and Applied Skin Physiology, 12/16/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address